z-logo
open-access-imgOpen Access
Spastic paraplegia due to SPAST mutations is modified by the underlying mutation and sex
Author(s) -
Livia Parodi,
Silvia Fenu,
Mathieu Barbier,
Guillaume Banneau,
Charles Duyckaerts,
Sophie Tézenas du Montcel,
MarieLorraine Monin,
Samia Ait Said,
Justine Guégan,
Chantal Tallaksen,
Bertrand Sablonniere,
Alexis Brice,
Giovanni Stévanin,
Christel Depienne,
Alexandra Dürr,
Myriem Abada,
Mathieu Anheim,
Dominique Bonneau,
Perrine Charles,
Pierre Clavelou,
Giulia Coarelli,
Paula Coutinho,
Rabab Debs,
N. Elleuch,
Claire Ewenczyk,
Imed Feki,
Xavier Ferrer,
Bertrand Fontaine,
Cyril Goizet,
Lucie GuyantMaréchal,
Didier Hannequin,
Solveig Heide,
Abdoul Kassar,
Pierre Labauge,
A Lagueny,
Isabelle Le Ber,
Timothée Lenglet,
Lionel Van Maldergem,
Cécilia Marelli,
Karine Nguyen,
Diana Rodriguez,
Tanya Stojkovic,
Alina Tataru,
Maya Tchikviladzé,
Christine Tranchant,
N. Vandenberghe
Publication year - 2018
Publication title -
brain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.142
H-Index - 336
eISSN - 1460-2156
pISSN - 0006-8950
DOI - 10.1093/brain/awy285
Subject(s) - penetrance , hereditary spastic paraplegia , missense mutation , frameshift mutation , genetics , medicine , mutation , biology , phenotype , gene
Hereditary spastic paraplegias (HSPs) are rare neurological disorders caused by progressive distal degeneration of the corticospinal tracts. Among the 79 loci and 65 spastic paraplegia genes (SPGs) involved in HSPs, mutations in SPAST, which encodes spastin, responsible for SPG4, are the most frequent cause of both familial and sporadic HSP. SPG4 is characterized by a clinically pure phenotype associated with restricted involvement of the corticospinal tracts and posterior columns of the spinal cord. It is rarely associated with additional neurological signs. However, both age of onset and severity of the disorder are extremely variable. Such variability is both intra- and inter-familial and may suggest incomplete penetrance, with some patients carrying mutations remaining asymptomatic for their entire life. We analysed a cohort of 842 patients with SPG4-HSP to assess genotype-phenotype correlations. Most patients were French (89%) and had a family history of SPG4-HSP (75%). Age at onset was characterized by a bimodal distribution, with high inter-familial and intra-familial variability, especially concerning first-degree relatives. Penetrance of the disorder was 0.9, complete after 70 years of age. Penetrance was lower in females (0.88 versus 0.94 in males, P = 0.01), despite a more diffuse phenotype with more frequent upper limb involvement. Seventy-seven per cent of pathogenic mutations (missense, frameshift, splice site, nonsense, and deletions) were located in the AAA cassette of spastin, impairing its microtubule-severing activity. A comparison of the missense and truncating mutations revealed a significantly lower age at onset for patients carrying missense mutations than those carrying truncating mutations, explaining the bimodal distribution of the age at onset. The age at onset for patients carrying missense mutations was often before 10 years, sometimes associated with intellectual deficiency. Neuropathological examination of a single case showed degeneration of the spinocerebellar and spinocortical tracts, as well as the posterior columns. However, there were numerous small-diameter processes among unusually large myelinated fibres in the corticospinal tract, suggesting marked regeneration. In conclusion, this large cohort of 842 individuals allowed us to identify a significantly younger age at onset in missense mutation carriers and lower penetrance in females, despite a more severe disorder. Neuropathology in one case showed numerous small fibres suggesting regeneration.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom